FDA recall Z-1283-2024

Fresenius Kabi USA, LLC · Class II · device

Product

LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Reason for recall

Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.

Distribution

US Nationwide distribution to the states of CA, CO, NJ, WI, UT.

Key facts

Status
Completed
Initiation date
2023-05-10
Report date
2024-03-20
Voluntary/Mandated
Voluntary: Firm initiated
Location
North Andover, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1283-2024